TGFB3 and cancer: Pelvic-peritoneal implants are shown to harbor concordat mutations mainly in the genes, TP53, ATM, ATR, TGFB3 Col3A1 and VCAM1, which suggests that populations of cancer cells obtained from different synchronous lesions are clonally correlated to an ancestral clone.